Issue 5/2023
Content (10 Articles)
An Opportune Time to Consider Glucose–Insulin–Potassium Therapy for Takotsubo Syndrome
John E. Madias
Etripamil Nasal Spray: Therapeutic Potential for Treating Paroxysmal Supraventricular Tachycardia
Jessica Huston, Ariana Genovese, Andrea Ashchi, Amanda DeLuca, Jordyn Wiener, Elias Deeb, Alexander Deeb, Rebecca F. Goldfaden
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Daniel Tobias Michaeli, Julia Caroline Michaeli, Sebastian Albers, Tobias Boch, Thomas Michaeli
Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells
Yilin Xiong, Yan Wang, Tao Yang, Yunmei Luo, Shangfu Xu, Lisheng Li
Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Sneha Annie Sebastian, Inderbir Padda, Eric J. Lehr, Gurpreet Johal
Ticagrelor or Clopidogrel as Antiplatelet Agents in Patients with Chronic Kidney Disease and Cardiovascular Disease: A Meta-analysis
Yinxue Guo, Pingyu Ge, Ziju Li, Jingxia Xiao, Lirui Xie
Efficacy of Pemafibrate Versus Fenofibrate Administration on Serum Lipid Levels in Patients with Dyslipidemia: Network Meta-Analysis and Systematic Review
Muhammad Shayan Khan, Ghulam Mujtaba Ghumman, Abdul Baqi, Jay Shah, Muhammad Aziz, Tanveer Mir, Ayesha Tahir, Srinivas Katragadda, Hemindermeet Singh, Mohammed Taleb, Syed Sohail Ali
A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States
Inmaculada Hernandez, Victoria Divino, Lin Xie, David W. Hood, Mitch DeKoven, Wanjiku Kariuki, Griffith Bell, Cristina Russ, Dong Cheng, Matthew Cato, Nipun Atreja, Dionne M. Hines
Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study
Wei-Chieh Lee, Chih-Yuan Fang, Yi-Hsuan Tsai, Yun-Yu Hsieh, Tien-Yu Chen, Yen-Nan Fang, Huang-Chung Chen, Po-Jui Wu, Hsiu-Yu Fang
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
Jose Seijas-Amigo, Mª José Mauriz-Montero, Pedro Suarez-Artime, Mónica Gayoso-Rey, Ana Estany-Gestal, Antonia Casas-Martínez, Lara González-Freire, Ana Rodriguez-Vazquez, Natalia Pérez-Rodriguez, Laura Villaverde-Piñeiro, Concepción Castro-Rubinos, Esther Espino-Faisán, Moisés Rodríguez-Mañero, Alberto Cordero, José R. González-Juanatey, Adrián Paz-Couce, Diego Rodriguez-Penas, Begoña Cardeso-Paredes, Ana Seoane-Blanco, María Moure-Gonzalez, Rita Soler-Martín, Luis Margusino-Framiñan, Ana Suarez-Rodriguez, Marisol Rodriguez-Cobos, Juan Rojo-Valdés, Irene Zarra-Ferro, Karina Lorenzo-Lorenzo, Cristina Casanova-Martinez, Carlos Crespo-Diz, María Dominguez-Guerra, María Elena González-Pereira, María Anido-García, Iveth Michelle Tajes-Gonzalez, Héctor Mozo-Peñalver, Alicia Silva-Lopez, Jose Luis Rodriguez-Sanchez, María Jesús García-Verde